Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00684671 |
Only subjects who participated in the primary study will be invited to participate in the extension phase and the challenge dose phase of this study.
Condition | Intervention | Phase |
---|---|---|
Hepatitis A Hepatitis B |
Biological: Twinrix Biological: Engerix-B Biological: Havrix Biological: HBVAXPRO Biological: Vaqta |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Challenge Dose Administration of Twinrix™ or Comparator 4 Years After Primary Vaccination. |
Estimated Enrollment: | 293 |
Study Start Date: | May 2008 |
Estimated Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Group C: Active Comparator |
Biological: HBVAXPRO
Intramuscular injection, single dose in the left deltoid.
Biological: Vaqta
Intramuscular injection, single dose in right deltoid.
|
Group B: Active Comparator |
Biological: Engerix-B
Intramuscular injection, single dose in left deltoid.
Biological: Havrix
Intramuscular injection, single dose in right deltoid.
|
Group A: Experimental |
Biological: Twinrix
Intramuscular injection, single dose in left deltoid.
|
Ages Eligible for Study: | 41 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
The following criteria should be checked at the time of study entry. If any apply, the subject must not be included in the study:
Belgium | |
GSK Investigational Site | |
Wilrijk, Belgium, 2610 | |
Czech Republic | |
GSK Investigational Site | |
Hradec Kralove, Czech Republic, 500 01 |
Study Director: | GSK Clinical Trials | GlaxoSmithKline |
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | 111572 |
Study First Received: | May 23, 2008 |
Last Updated: | October 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00684671 |
Health Authority: | Belgium: Federal Agency for Medicinal Products and Health Products |
Combined hepatitis A and B vaccine Immune memory > 41 years old |
Virus Diseases Hepatitis Liver Diseases Digestive System Diseases Hepatitis B |
Picornaviridae Infections Hepatitis, Viral, Human Hepatitis A DNA Virus Infections Enterovirus Infections |
RNA Virus Infections Hepadnaviridae Infections |